Mutations in the Gene PRRT2 Cause Paroxysmal Kinesigenic Dyskinesia with Infantile Convulsions
Tarih
2012Yazar
FU, Ying-Hui
Baykan, BETÜL
RUDOLF, Gabrielle
SAIKI, Shinji
SOONG, Bing-Wen
SWOBODA, Kathryn J.
Tucker, Sam
MAAS, James
EDWARDS, Robert
ASHIZAWA, Tetsuo
Bhatia, Kailash
Bressman, Susan
BRUNO, Michiko K.
BRUNT, Ewout R.
CARABALLO, Roberto
ECHENNE, Bernard
FEJERMAN, Natalio
FRUCHT, Steve
GURNETT, Christina A.
HIRSCH, Edouard
Houlden, Henry
JANKOVIC, Joseph
LEE, Wei-Ling
LEE, Hsien-Yang
HUANG, Yong
ROLL, Patrice
ROBERSON, Elisha D. O.
HERMANN, Mark
QUINN, Emily
Wood, Nicholas
Hanna, Michael
BOWCOCK, Anne M.
SZEPETOWSKI, Pierre
PTACEK, Louis J.
BRUNEAU, Nadine
Lynch, David R.
MOHAMMED, Shehla
MUELLER, Ulrich
NESPECA, Mark P.
RENNER, David
ROCHETTE, Jacques
Üst veri
Tüm öğe kaydını gösterÖzet
Paroxysmal kinesigenic dyskinesia with infantile convulsions (PKD/IC) is an episodic movement disorder with autosomal-dominant inheritance and high penetrance, but the causative genetic mutation is unknown. We have now identified four truncating mutations involving the gene PRRT2 in the vast majority (24/25) of well-characterized families with PKD/IC. PRRT2 truncating mutations were also detected in 28 of 78 additional families. PRRT2 encodes a proline-rich transmembrane protein of unknown function that has been reported to interact with the t-SNARE, SNAP25. PRRT2 localizes to axons but not to dendritic processes in primary neuronal culture, and mutants associated with PKD/IC lead to dramatically reduced PRRT2 levels, leading ultimately to neuronal hyperexcitability that manifests in vivo as PKD/IC.
Koleksiyonlar
- Makale [92796]